Home > Compound List > Compound details
25389-94-0 molecular structure
click picture or here to close

(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-3-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}oxane-3,4,5-triol

ChemBase ID: 1043
Molecular Formular: C18H36N4O11
Molecular Mass: 484.49864
Monoisotopic Mass: 484.23805799
SMILES and InChIs

SMILES:
O([C@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CN)[C@@H]1[C@H](C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)N)O)N)N
Canonical SMILES:
OC[C@H]1O[C@H](O[C@H]2[C@H](N)C[C@@H]([C@H]([C@@H]2O)O[C@H]2O[C@H](CN)[C@H]([C@@H]([C@H]2O)O)O)N)[C@@H]([C@H]([C@@H]1O)N)O
InChI:
InChI=1S/C18H36N4O11/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17/h4-18,23-29H,1-3,19-22H2/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-/m1/s1
InChIKey:
SBUJHOSQTJFQJX-NOAMYHISSA-N

Cite this record

CBID:1043 http://www.chembase.cn/molecule-1043.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-3-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}oxane-3,4,5-triol
IUPAC Traditional name
kanamycin
Brand Name
Bekanamycin
Kanamycin A
Kanamycin B
Kenamycin A
Klebcil
Synonyms
KAN
Aminodeoxykanamycin
Kanamycin Base
Kanamycin Sulfate
Nebramycin Factor 5
Kanamycin
Kanamycin solution from Streptomyces kanamyceticus
CAS Number
25389-94-0
8063-07-8
MDL Number
MFCD00070289
PubChem SID
160964506
46508178
PubChem CID
6032

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
Acid pKa 12.109839  H Acceptors 15 
H Donor 11  LogD (pH = 5.5) -18.059649 
LogD (pH = 7.4) -12.666778  Log P -7.0609136 
Molar Refractivity 106.1345 cm3 Polarizability 45.27121 Å3
Polar Surface Area 282.61 Å2 Rotatable Bonds
Lipinski's Rule of Five false 
Log P -3.1  LOG S -0.72 
Solubility (Water) 9.23e+01 g/l 

PROPERTIES

PROPERTIES

Physical Property Safety Information Product Information Bioassay(PubChem)
Apperance
liquid expand Show data source
Hydrophobicity(logP)
-6.3 expand Show data source
European Hazard Symbols
Toxic Toxic (T) expand Show data source
German water hazard class
2 expand Show data source
Risk Statements
61 expand Show data source
Safety Statements
53-45 expand Show data source
GHS Pictograms
GHS08 expand Show data source
GHS Signal Word
Danger expand Show data source
GHS Hazard statements
H360 expand Show data source
GHS Precautionary statements
P201-P308 + P313 expand Show data source
Storage Temperature
2-8°C expand Show data source
Concentration
10 mg/mL in 0.9% NaCl expand Show data source
50 mg/mL in 0.9% NaCl expand Show data source
Suitability
suitable for cell culture expand Show data source
Impurities
endotoxin, tested expand Show data source
Sterility
sterile-filtered expand Show data source

DETAILS

DETAILS

DrugBank DrugBank Sigma Aldrich Sigma Aldrich
DrugBank - DB01172 external link
Item Information
Drug Groups approved
Description Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. [PubChem]
Indication For treatment of infections where one or more of the following are the known or suspected pathogens: E. coli, Proteus species (both indole-positive and indole-negative), E. aerogenes, K. pneumoniae, S. marcescens, and Acinetobacter species.
Pharmacology Kanamycin is an aminoglycoside antibiotic. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit, causing misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth. Aminoglycosides are useful primarily in infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, but other types of antibiotics are more potent and less damaging to the host. In the past the aminoglycosides have been used in conjunction with penicillin-related antibiotics in streptococcal infections for their synergistic effects, particularly in endocarditis. Aminoglycosides are mostly ineffective against anaerobic bacteria, fungi and viruses.
Toxicity Mild and reversible nephrotoxicity may be observed in 5 - 25% of patients. Amikacin accumulates in proximal renal tubular cells. Tubular cell regeneration occurs despite continued drug exposure. Toxicity usually occurs several days following initiation of therapy. May cause irreversible ototoxicity. Otoxocity appears to be correlated to cumulative lifetime exposure. Drug accumulation in the endolymph and perilymph of the inner ear causes irreversible damage to hair cells of the cochlea or summit of ampullar cristae in the vestibular complex. High frequency hearing is lost first with progression leading to loss of low frequency hearing. Further toxicity may lead to retrograde degeneration of the 8th cranial (vestibulocochlear) nerve. Vestibular toxicity may cause vertigo, nausea, vomiting, dizziness and loss of balance.
Oral LD50 is 17500 mg/kg in mice, over 4 g/kg in rats, and over 3 g/kg in rabbits.
Affected Organisms
Enteric bacteria and other eubacteria
Absorption Kanamycin is rapidly absorbed after intramuscular injection and peak serum levels are generally reached within approximately one hour. Poor oral and topical absorption except with severe skin damage.
Half Life 2.5 hours
External Links
Wikipedia
RxList
Drugs.com
Sigma Aldrich - K0129 external link
Application
Recommended for use in cell culture applications at 10 ml/L.
Biochem/physiol Actions
Mode of Action: Binds to 70S ribosomal subunit; inhibits translocation; elicits miscoding.Antimicrobial spectrum: Gram-negative and Gram-positive bacteria, and mycoplasma.
Caution
Stable at 37°C for 5 days.
Protocols & Applications
Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information
Sigma Aldrich - K0254 external link
Application
Used as a selection agent for cells transformed with kanamycin B (neoR, kanR) resistance gene. Recommended for use in cell culture applications at 2 ml/L.
Biochem/physiol Actions
Mode of Action: Binds to 70S ribosomal subunit; inhibits translocation; elicits miscoding.Antimicrobial spectrum: Gram-negative and Gram-positive bacteria, and mycoplasma.
Caution
Stable at 37 °C for 5 days.
Protocols & Applications
Antibiotic Selector for application, solubility, solution stability, working concentration, and mode of action information

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle